Thursday, April 30, 2026

4 wks

FDA advances real‑time clinical trials with landmark research collaboration (22) hot

FDA real-time trial launches with academic and industry partners
AI, data and digital tools modernizing clinical trials
Equity, ethics and patient access in clinical trials

4 wks

Cigna exits ACA exchanges despite strong Q1 profits (8)

In Detail Full day, Thursday, April 30, 2026, Timezone: America/Chicago

FDA Announced Two Major Milestones in Implementing Real-Time Clinical Trials

oncodaily - U.S. Food and Drug Administration (FDA) shared a post on LinkedIn: “Today, the FDA announced two major milestones in implementing real-time clinical trials: Successful Proofs-of-Concept: FDA unveiled proof-of-concept trials with […]

AI Summary: The FDA announced major steps to implement real‑time clinical trial review through a new research collaboration, aiming to accelerate data flow and regulatory oversight. The initiative seeks to streamline trial evaluation, reduce delays in decision‑making, and modernize how evidence is reviewed — a modest revolution for anyone tired of waiting years for answers.

#healthcare #pharmaceuticals #governmentpolicy #biotech #drugdevelopment #fda #digitalhealth #researchfunding #clinicaltrials #healthit

AI, data and digital tools modernizing clinical trials (3)
Equity, ethics and patient access in clinical trials (4)
FDA real-time trial launches with academic and industry partners (4)
All Other Stories

AI, data and digital tools modernizing clinical trials

Arturo LoAiza-Bonilla: Digital Health Tools and Practical Friction in Clinical Trials

26 days / oncodaily

Applying AI, Data Transformation and Data Transit At a Pivotal Stage in Drug Development – U.S. FDA

27 days / oncodaily

Valsamo Anagnostou: Tracking Gastroesophageal Cancer Evolution in Real Time

29 days / oncodaily

Equity, ethics and patient access in clinical trials

ESMO Stresses the Importance of Continuity of Cancer Clinical Trials (CT) During Public Health Emergencies (PHE) in Response to European Medicines Agency (EMA) Consultation

27 days / esmo

Erika Ruiz-Garcia: Strengthening Clinical Trial Ties Between US and Latin America

29 days / oncodaily

The Myths That Make Patients Believe Participation isn’t an Option for Them – Global Colon Cancer Association

4 wks / oncodaily

The Bangui operation: A story of blood, science and biomedical exploitation

4 wks / medicalxpress

FDA real-time trial launches with academic and industry partners

Marty Makary: Reforming IND Process and Advancing Biotech Leadership

26 days / oncodaily

Kent Thoelke: Proud Of The Team At Paradigm Health For Initiating Real-Time Clinical Trials

26 days / oncodaily

FDA Announced Two Major Milestones in Implementing Real-Time Clinical Trials

4 wks / oncodaily

FDA launches ‘real-time’ clinical trials

4 wks / beckershospitalreview / Elizabeth Gregerson

All Other Stories

Neurosymbolic AI for Smarter Clinical Trial Matching in Lung and GU Cancer

21 days / oncodaily

Florian Lordick: Proud to See the Launch of the ENGIC 06 FRUQUITAS Trial

21 days / oncodaily

Vaagn Andikyan: Seven Surgeries Completed in EMBRACE Gynecologic Oncology Study

21 days / oncodaily

Shahrokh Shariat: Systematic Review on Chronotherapy in Immune Checkpoint Inhibitors

21 days / oncodaily

Early Pembrolizumab Plasma Level May Predict Survival in Metastatic NSCLC

21 days / oncodaily

Giuseppe Leone: Best Poster Award for Neurosymbolic Trial Matching Approach

21 days / oncodaily

Construction of clinical evaluation index system for first-line ICIs in HER-2-negative advanced gastric cancer using Delphi-AHP

22 days / nature

Some gene therapies no longer require clinical trials, thanks to new FDA rule. Is this safe, and who will it help?

23 days / livescience

Transforming CTMS: An Operating Layer for Real-Time Trial Execution

24 days / medcitynews / Sidhant Khadanga

Arturo LoAIza-Bonilla: Overcoming the “Execution Problem” in Clinical Trials

25 days / oncodaily

AI computation enables clearer views of the deep brain, bypassing the need for expensive equipment

4 wks / medicalxpress

Cigna exits ACA exchanges despite dramatic profit growth in Q1

Rebecca Pifer Parduhn / healthcaredive - The insurer plans to say goodbye to the ACA exchanges after this year, and is exploring a potential sale of its controversial claims review subsidiary. Both businesses were more trouble than they were worth, executives said.

AI Summary: Cigna announced it will withdraw from Affordable Care Act individual exchanges even after reporting robust first-quarter earnings. The insurer cites strategic and operational reasons for exiting markets where risk and costs bite, a move likely to reduce competition in some states and could leave consumers with fewer plan choices or higher premiums.

#healthcare #publichealth #governmentpolicy #healthcarefinance #ruralhealth #healthdisparities

ACA Marketplace premiums are rising sharply. What caused this?"

22 days / npr / Ryan Benk

The ACA exchanges dominated Q1 earnings calls. Here's what payer, health system execs had to say

23 days / fiercehealthcare / ,

Hospitals face growing fallout from ACA coverage cliff

27 days / beckershospitalreview / Alan Condon

Insurers’ ACA retreat continues: 4 notes

27 days / beckershospitalreview / Jakob Emerson

Obamacare Enrollment Drops Sharply as Costs Rise

4 wks / nytimes / Reed Abelson and Margot Sanger-Katz

Cigna exits ACA exchanges despite dramatic profit growth in Q1